FLUDEOXYGLUCOSE F-18
NDC 78714-001, FLUDEOXYGLUCOSE F-18, injection, from Barbara Ann Karmanos Cancer Hospital.
- Product NDC
- 78714-001
- Status
- Listed
- Labeler
- Barbara Ann Karmanos Cancer Hospital
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204385
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/78714-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUDEOXYGLUCOSE F-18300 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 78714-001-30 | 78714000130 | 30 mL in 1 VIAL, GLASS (78714-001-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/e3791140-2e52-48c5-9849-536d5e4275e5
Use it
Look up 78714-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/78714-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 78714-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.